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Platelet activation independent of
pulmonary inflammation contributes
to diesel exhaust particulate-induced
promotion of arterial thrombosis
Caroline M. Tabor1, Catherine A. Shaw1, Sarah Robertson1, Mark R. Miller1, Rodger Duffin2, Ken Donaldson2,
David E. Newby1 and Patrick W. F. Hadoke1*
Abstract
Background: Accelerated thrombus formation induced by exposure to combustion-derived air pollution has
been linked to alterations in endogenous fibrinolysis and platelet activation in response to pulmonary and
systemic inflammation. We hypothesised that mechanisms independent of inflammation contribute to accelerated
thrombus formation following exposure to diesel exhaust particles (DEP).
Methods: Thrombosis in rats was assessed 2, 6 and 24 h after administration of DEP, carbon black (CB; control carbon
nanoparticle), DQ12 quartz microparticles (to induce pulmonary inflammation) or saline (vehicle) by either intra-tracheal
instillation (0.5 mg, except Quartz; 0.125 mg) or intravenous injection (0.5 mg/kg). Thrombogenicity was assessed by
carotid artery occlusion, fibrinolytic variables and platelet-monocyte aggregates. Measures of inflammation were
determined in plasma and bronchoalveolar lavage fluid. Tissue plasminogen activator (t-PA) and plasminogen
activator inhibitor (PAI)-1 were measured following direct in vitro exposure of human umbilical vein endothelial
cells (HUVECs) to DEP (10–150 μg/mL).
Results: Instillation of DEP reduced the time to thrombotic occlusion in vivo, coinciding with the peak of DEP-induced
pulmonary inflammation (6 h). CB and DQ12 produced greater inflammation than DEP but did not alter time to
thrombotic occlusion. Intravenous DEP produced an earlier (2 h) acceleration of thrombosis (as did CB) without
pulmonary or systemic inflammation. DEP inhibited t-PA and PAI-1 release from HUVECs, and reduced the t-PA/
PAI-1 ratio in vivo; similar effects in vivo were seen with CB and DQ12. DEP, but not CB or DQ12, increased
platelet-monocyte aggregates.
Conclusion: DEP accelerates arterial thrombus formation through increased platelet activation. This effect is
dissociated from pulmonary and systemic inflammation and from impaired fibrinolytic function.
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Background
The association between air pollution and cardiovascular
disease is well-established [1], with exposure to traffic-
derived pollutants implicated in acute myocardial infarc-
tion [2, 3]. The adverse cardiovascular effects of airborne
pollution have been attributed to combustion-derived
particulate matter (PM), especially ultrafine particles
from diesel exhaust (DEP), that has a large reactive
surface area and can penetrate deep within the lung
(reviewed in [4]). Recent investigations suggest that DEP
[5] and ambient particulate matter [6, 7] increase cardio-
vascular events by accelerating thrombosis [2].
The mechanisms responsible for PM-induced en-
hancement of thrombosis remain controversial. Diesel
exhaust inhalation in humans produced endothelial cell
dysfunction 2–24 hours after exposure [8–10], accom-
panied by impaired endogenous fibrinolysis [8], in-
creased thrombogenicity and platelet activation [5].
These effects could be directly attributed to the exhaust
particles as they were markedly reduced following removal
of particles from the exhaust [11, 12]. Investigations using
appropriate animal models support the contention that
DEP increases the likelihood of thrombus formation [13,
14]. However, whilst several different mechanisms for en-
hanced coagulation in response to particles have been im-
plicated (including impaired fibrinolysis [7] and platelet
activation [7, 15, 16]), there remains much disagreement.
A recent study in mice, indicated that increased thrombus
formation could be attributed to PM-induced pulmonary
and systemic inflammation via multiple mechanisms [7];
including an increased tumour necrosis factor (TNF)-α-
dependent impairment of fibrinolysis and an interleukin
(IL)-6-dependent activation of coagulation. However,
whether the cardiovascular effects of DEP require direct
interaction with the lung is uncertain since intravenous
(i.v.) injection caused systemic and pulmonary inflamma-
tion associated with alterations in the cardiovascular
system in spontaneously hypertensive rats [17].
There is also some evidence that DEP can, at least
acutely, increase coagulation independent of pulmonary
inflammation. Inhibition of pulmonary inflammation 1 h
after exposure of hamsters to DEP had no effect on
coagulation or platelet activation, whereas the same
intervention did reduce DEP-mediated enhancement of
coagulation 3 and 24 h after exposure [18]. It was sug-
gested that penetration of DEP, or components of DEP,
into the blood could account for this early pro-thrombotic
effect. This would certainly be consistent with the demon-
stration that direct exposure of blood to DEP can enhance
thrombus formation ex vivo [1].
Whilst previous investigations have considered the
role of pulmonary inflammation, uncertainty remains
about its influence on the pro-thrombotic actions of
DEP. The current investigation addressed the hypothesis
that exposure to DEP induces an increase in thrombosis
independent of pulmonary inflammation. This was ad-
dressed in vivo by using (1) intra-pulmonary and (2) intra-
venous administration of DEP or appropriate ‘control
particles’ (carbon black, DQ12 quartz). These studies were
complemented by in vitro experiments to determine
whether direct exposure to DEP alters endogenous fibrin-
olysis in endothelial cells.
Results
IT instillation of particles
IT instillation (500 μg DEP/rat) resulted in successful
administration of DEP, with particle aggregates evident
in alveoli (but not in liver, kidney or carotid artery
thrombi) collected 2 or 6 h after administration (data
not shown).
Pulmonary & systemic inflammation
IT instillation of DEP, CB or DQ12 quartz induced clear,
transient pulmonary inflammation with a marked influx of
cells (predominantly neutrophils), peaking 6 h post instil-
lation (Fig. 1). The responses produced by CB and DQ-12
particles were greater than those produced by DEP (Fig. 1).
Cellular infiltration was accompanied by increased con-
centrations of interleukin (IL)-6 in bronchoalveolar lavage
fluid (BALF) 6 h after instillation (Fig. 2i), although appar-
ent increases in tumour necrosis factor (TNF)-α (Fig. 2ii)
and C-reactive protein (CRP; Fig. 2iii) did not achieve stat-
istical significance. The indication that the pulmonary
inflammation produced by control particles was more
marked than that induced by DEP was supported by the
demonstration that CB increased both IL-6 (Fig. 2i) and
CRP (Fig. 2iii), whilst DQ12 quartz increased CRP concen-
trations in BALF (Fig. 2iii). Furthermore, control particles
induced systemic inflammation: concentrations of CRP in
plasma (6 h) were increased by IT instillation of CB or
DQ12 quartz, but unaltered after IT instillation of DEP
(Fig. 2v). Plasma concentrations of IL-6 and TNFα were
not affected by IT instillation of any of the particles (data
not shown).
Thrombus formation
FeCl3 produced thrombus formation, leading to total oc-
clusion (cessation of blood flow) of the carotid artery after
12–15 min in vehicle-treated rats. IT instillation of DEP
(Fig. 3i) produced a pattern of reduced time-to-occlusion
at all three time-points assessed (2, 6 & 24 h), with the
difference achieving significance 6 h after exposure
(DEP 9.4 ± 0.8 min vs vehicle 13.8 ± 0.7 min; n = 6). In
contrast, neither CB nor DQ12 quartz accelerated
thrombus formation (Fig. 3ii).
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Endogenous fibrinolysis
Plasma PAI-1 and t-PA concentrations were measured
to determine whether altered endogenous fibrinolysis
could account for the accelerated thrombosis induced by
DEP. These measurements demonstrated that IT instilla-
tion of DEP reduced plasma t-PA and increased PAI-1
concentrations, reducing the t-PA:PAI-1 ratio (Fig. 3(iii)).
Instillation of CB or DQ12 quartz produced a similar
impairment in fibrinolytic function (Fig. 3(iii)).
Platelet-monocyte aggregation
Platelet-monocyte aggregation was increased 6 h after IT
instillation of DEP (Fig. 3(iv)). In contrast, instillation of
CB or DQ12 Quartz had no effect.
IV injection of particulate
Successful administration of particles to the circulation
was confirmed by the identification of DEP aggregates in
sections of liver (although not in kidney) 2 h after intra-
venous injection (data not shown). No particles were iden-
tified in these organs 6 or 24 h after injection.
Absence of pulmonary and systemic inflammation
In contrast to IT instillation, i.v. injection of DEP or
CB did not cause pulmonary inflammation. There was
no influx of inflammatory cells into the lung (Fig. 4i),
and no change in the inflammatory cell populations
(Fig. 4ii & iii) or the cytokine concentrations in
BALF: TNFα (Additional file 1: Figure S1i), CRP
Fig. 1 Particle instillation causes pulmonary neutrophil accumulation. (i) Monocytes and neutrophils in bronchoalveolar lavage fluid (BALF) were
identified by nuclear morphology in haematoxylin and eosin-stained cytospins after in vivo administration of diesel exhaust (DEP; 2, 6 or 24 h)
or control (carbon black (CB); DQ12 quartz; 6 h) particle solutions. DEP and CB were associated with inflammatory cells (arrows) or phagocytosed by
macrophages (arrow heads). There was no evidence of phagocytosis of quartz particles. Magnification ×400. (ii) Instillation of DEP (0.5 mg/rat; black
columns) caused a transient increase in total cell number that peaked 6 h following administration. CB (0.5 mg/rat; light grey columns) or DQ12 quartz
(0.125 mg/rat; dark grey columns) also increased cell number 6 h after instillation. (iii) Increases in total inflammatory cell number were due to
an increase in neutrophils. Data are mean ± s.e.mean (n = 6) and were compared with appropriate control using Student’s unpaired t-test.
*P < 0.05, ***P < 0.001
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(Additional file 1: Figure S1ii). IL-6 concentrations were
below the limit of detection (data not shown). In addition,
there was no evidence of systemic inflammation as plasma
concentrations of CRP, IL-6 and TNFα were unaffected by
i.v. DEP. Interestingly, plasma CRP (but not IL-6 or TNFα;
data not shown) was increased 2 h after injection of CB
(Additional file 1: Figure S1iii).
Thrombus formation
In the FeCl3-induced thrombosis model, DEP (0.5 mg/
kg, i.v.) produced a transient reduction in time-to-
occlusion 2 h following administration, which was no
longer evident after 6 or 24 h (Fig. 5ii). The control
particles, CB, also produced a small reduction in time-
to-occlusion at the 2 h time-point (Fig. 5ii). No
Fig. 2 Influence of particle instillation on pro-inflammatory cytokines. Instillation of diesel exhaust particles (DEP) increased IL-6 concentrations in
bronchoalveolar lavage fluid (BALF) (i), but apparent increases of tumour necrosis factor (TNF)-α (ii) and C-reactive protein (CRP) (iii) did not achieve
significance. Carbon black (CB) increased concentrations of IL-6 and CRP, whilst DQ12 quartz increased CRP. (iv) In plasma, carbon black (CB; light grey
columns) or DQ12 quartz (dark grey columns), increased concentrations of CRP compared with controls (white columns), whereas DEP (black columns)
did not. Data are mean ± s.e.mean (n = 6) and were compared with relevant control using Student’s unpaired t-test or one-way ANOVA, as appropriate.
*P < 0.05, ***P < 0.001. ns = not significant
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particles were identified by histological analysis of the
thrombosed vessel.
Endogenous fibrinolysis
Injection (i.v) of DEP or CB reduced plasma t-PA and
increased PAI-1 concentrations, reducing the t-PA:PAI-1
ratio (Fig. 5(iii)).
Platelet-monocyte aggregation
Platelet-monocyte aggregation was increased 2 h after
i.v. injection, whereas exposure to CB had no effect
(Fig. 5(iv)).
In vitro exposure of HUVECs to DEP
In order to determine whether DEP can directly alter the
fibrinolytic system in endothelial cells, cultured human
umbilical vein endothelial cells (HUVECs) were exposed
(16 h) to DEP (10–150 μg/mL) or vehicle, with or with-
out thrombin (1.0 U/ml, 24 h) stimulation.
Exposure to DEP was not cytotoxic as treatment had
no effect on cell viability as measured by LDH assay
(Additional file 2: Figure S2). Pre-exposure to DEP re-
duced expression of t-PA (Fig. 6i) and PAI-1 (Fig. 6ii).
Exposure to DEP (150 μg/ml; 6–24 h) also reduced t-PA
antigen concentrations (Fig. 6iii) and PAI-1 activity
(Fig. 6iv) in culture media. Stimulation with thrombin
had no effect on t-PA antigen levels (Fig. 6v) but in-
creased PAI-1 activity (Fig. 6vi) in media, an effect that
was attenuated in the presence of DEP.
Discussion
This investigation addressed the hypothesis that exposure
to DEP induces accelerated thrombus formation inde-
pendent of pulmonary inflammation. This was achieved
by comparing the effects of pulmonary and systemic DEP
administration with appropriate control particles (CB, a
“clean” carbon particle to control for the nano-carbon
core of DEP and DQ12 quartz, a large pro-inflammatory
particle that will not translocate into the blood [19, 20]).
Instillation and injection of DEP (and other nanoparticles)
have been shown to increase pulmonary and systemic
inflammation, with circulating levels of IL-6, TNFα and
leukotriene-B4 elevated in the rat [14, 20–24]. The current
investigation demonstrated that control particles caused
pulmonary and/or systemic inflammation but did not pro-
mote thrombosis. In contrast, DEP-induced acceleration
of thrombus formation was evident in the absence of
pulmonary or systemic inflammation. The outcomes of
these experiments are summarised in Table 1.
Fig. 3 Influence of particle instillation on thrombogenesis. Diesel exhaust (DEP; black colums) or control (carbon black (CB), light grey columns;
DQ12 quartz, dark grey columns) particles were administered by intra-tracheal instillation 2, 6 or 24 h before induction of arterial thrombosis. (i)
Instillation of DEP (0.5 mg/rat) reduced time to occlusion (P < 0.05), compared with the vehicle (open columns) 6 h after administration. Apparent
reductions in time to occlusion 2 h and 24 h after administration did not achieve significance. (ii) Control particles (CB (0.5 mg/rat) or DQ12 quartz
(125 mg/rat;)) did not alter time to occlusion 6 h after instillation. (iii) The ratio of tissue plasminogen activator (t-PA) to plasminogen activator inhibitor
(PAI)-1 was reduced in the plasma of rats following intra-tracheal (IT) instillation of DEP, CB or DQ12 quartz. (iv) IT instillation of DEP, but not CB
or DQ12 quartz increased platelet-monocyte interactions. Data are mean ± s.e.mean (n = 6) and were compared with relevant controls using one-way
((ii, (iii), (iv)) or two way (i) ANOVA. *P < 0.05, **P < 0.01 and ***P < 0.001
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Inflammation and accelerated thrombosis following
intra-tracheal instillation of DEP
Intra-tracheal (IT) instillation has been used extensively
to investigate the effects of pulmonary exposure to a
number of different particles [13, 24, 25]. It provides ex-
cellent alveolar penetration and distribution, and allows
direct comparison of different particle types, with in-
creased thrombus formation and platelet activation
reported after pulmonary instillation of silica [26], titan-
ium dioxide (TiO2) nanorods [27], ambient particulate
matter [14], and carbon nanotubes [28]. Instillation has
the advantage of ensuring direct administration of a con-
trolled particle dose, whereas with inhalation there can
be uncertainty about the proportion of particles that ac-
tually reaches the lungs (due to retention in the nasal
cavity) [29]. IT instillation or inhalation of combustion-
derived particles produce similar effects on thrombus
formation in vivo [7]. The dose of DEP used for IT instilla-
tion (500 μg DEP/rat) is comparable with previous studies
in animals (5–500 μg/animal for hamsters [13, 21, 24]) ex-
ploring particle activity, and can be used to consistently
induce pulmonary inflammation.
The accelerated thrombosis induced 6 h after IT instilla-
tion of DEP was consistent with the pro-thrombotic effect
described both in clinical [5, 8–10], and in animal (ham-
sters [13, 21, 30], mice [14, 22], or rats [23, 31]) studies.
This enhanced thrombus formation was co-incident with
the peak in pulmonary inflammation. Whilst this would
be consistent with thrombosis increasing as a conse-
quence of pulmonary inflammation [7], neither CB nor
Fig. 4 Intravenous injection of diesel exhaust particles or carbon black does not cause pulmonary neutrophil accumulation. (i) Example cytospins
of cells within bronchoalveolar lavage fluid (BALF) recovered 2, 6 or 24 h following injection of diesel exhaust particles (DEP) or 2 h after intravenous
injection of carbon black (CB) solutions. Staining: haematoxylin and eosin, magnification ×400. (ii) Systemic injection of DEP (black bars) or
CB (light grey bars) did not increase the total number of cells in BALF. (iii) Differential analysis confirmed that the majority of cells were macrophages,
both in saline-treated (white columns) and in particle-treated rats. Data are mean ± s.e.mean (n = 6). All comparisons with saline-treated control were
statistically non-significant; P > 0.05 using two-way ANOVA (DEP vs Saline) or Student’s unpaired t-test CB vs Saline)
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DQ12 quartz (which both induced inflammation) accel-
erated thrombus formation. This contrasts with the
relationship between increased thrombosis and pulmon-
ary inflammation reported for a number of different parti-
cles (silica [26], TiO2 [27], carbon nanotubes [28], DEP
[13, 22]). More recent evidence, however, has suggested
that CB-induced thrombogenic effects are independent of
pulmonary and systemic inflammation [32].
The possibility that increased thrombosis is the result
of impaired endogenous fibrinolysis has been indicated
in a number of investigations [3]. Endothelial t-PA re-
lease was reduced in healthy volunteers [8] and in men
with stable coronary heart disease [9] 2–6 hours after
exposure to DE. The particulate constituents of these
emissions contributed to the impaired t-PA release [11].
Impaired endogenous fibrinolysis has also been reported
in some (but not all [33, 34]) studies in animals, with
increased PAI-1 and reduced tissue factor pathway in-
hibitor following exposure to urban particulate matter
[7, 14, 35]. The timing of these changes suggests involve-
ment of an inducible pathway or changes in protein
synthesis. Whether these changes are secondary to
effects in the lung or are a consequence of direct inter-
action of DEP with the arterial wall has not been deter-
mined. The presence of pulmonary and systemic
inflammation following particle administration may be
expected to influence fibrinolysis since chronic inflam-
mation is associated with impairment of the endogenous
fibrinolytic system in vivo [36] and in cultured endothe-
lial cells [37]. Furthermore, reduction of systemic inflam-
mation (with the antioxidant ascorbic acid) restored
fibrinolytic function in chronic smokers [38]. However,
whereas our demonstration that IT instillation of DEP
alters the endogenous fibrinolytic system is consistent
with the impaired fibrinolysis reported after inhalation
of DE in humans [8], the use of control particles indi-
cated that altered fibrinolysis could not be the sole cause
of increased thrombosis following instillation. CB or
DQ12 quartz, which produced a similar impairment in
fibrinolytic function, did not alter thrombus formation.
These results suggest, therefore, that altered endogenous
fibrinolysis may be just one component of DEP-
mediated acceleration of thrombosis. Interestingly, al-
though pulmonary inflammation induced by urban par-
ticulate matter can alter endogenous fibrinolysis
(increased PAI-1) through a TNF-α-mediated process, it
activates coagulation via a distinct IL-6-mediated path-
way [7, 39, 40]. The mechanism responsible for DQ12-
induced alteration of fibrinolytic function has not been
identified, but may be related to the ability of particulate
Fig. 5 Influence of particle injection on thrombogenesis. Diesel exhaust (DEP; black columns) or control particles (carbon black (CB, grey columns)) were
administered by intravenous injection 2, 6 or 24 h before induction of arterial thrombosis. (i) Injection of DEP (0.5 mg/rat) reduced time
to occlusion (P < 0.05), compared with saline-treated controls (open columns) 2 h (but not 6 or 24 h) after administration. (ii) Injection of carbon black
(CB (0.5 mg/rat)) produced a similar reduction in time to occlusion (P < 0.05). (iii) The ratio of tissue plasminogen activator (t-PA) to plasminogen
activator inhibitor (PAI)-1 was reduced in the plasma of rats after intravenous injection (IV; 2 h post exposure) of DEP or CB. (iv) Platelet-monocyte
interaction was increased following IV administration of DEP but not CB. Data are mean ± s.e.mean (n = 6) and were compared with relevant
controls using two way ANOVA (DEP vs Saline) or Student’s unpaired t-test (CB vs Saline). *P < 0.05, **P < 0.01, ***P < 0.001
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exposure to stimulate cytokine release from inflamma-
tory cells [41] or release of an as yet unidentified medi-
ator into the circulation [42].
Since our data suggest that alteration of endogenous
fibrinolysis cannot solely account for acceleration of
thrombosis, we addressed the role of platelet activation.
Instillation of polystyrene particles increased platelet ac-
tivation [43] and platelet-granulocyte aggregation in ex-
perimental animals [14]. The increase in platelet-
monocyte aggregation 6 h after IT instillation of DEP in
our investigation coincided with accelerated thrombus
formation. This is consistent with previous work [3], and
with a clinical study from our group [9]. In contrast,
exposure to CB or DQ12 quartz had no effect, paral-
leling the pattern of thrombus effects across these
particles. Thus, in contrast to inflammation and al-
tered fibrinolysis, platelet activation was only seen fol-
lowing exposure to the particle (DEP) that accelerated
thrombosis.
Accelerated thrombosis without inflammation following
i.v. injection of DEP
In addition to the role of inflammation, the cardiovascu-
lar consequences of particle exposure have also been
Fig. 6 Diesel exhaust particles alter the endogenous fibrinolytic system in HUVECs. Human umbilical vein endothelial cells were exposed to diesel
exhaust particles (DEP; 100 μg/ml, 16 h, black columns) or vehicle (white columns) then incubated in the presence or absence of thrombin (1.0 U/ml,
24 h). Pre-exposure to DEP reduced expression of (i) tissue plasminogen activator (t-PA) and (ii) plasminogen activator inhibitor (PAI-1). Exposure
to DEP (150 μg/ml; 6–24 h) also reduced (iii) t-PA antigen concentrations and (iv) PAI-1 activity in culture media. Stimulation with throm-
bin did not significantly increase t-PA antigen levels in media (v) but increased PAI-1 activity (vi). Thrombin-stimulated PAI-1 activity was suppressed
in cells pre-incubated with DEP. Data are mean ± s.e.mean (n = 6). Comparisons were made using Student’s unpaired t-test;
**P < 0.01, ***P < 0.001
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attributed variously to alteration of the autonomic ner-
vous system, translocation of particles from the lung into
the systemic circulation, and oxidative stress [3]. Particle
translocation has attracted attention since direct (i.v.)
administration of particles to the blood increases throm-
bosis in vivo [13]. This may be due to direct effects on
components of the cardiovascular system since ex vivo
administration of DEP to blood accelerates clot
Table 1 Comparative summary of data from experiments using I.T. instillation (in vivo), I.V. injection (in vivo) and cultured
endothelial cells (in vitro)
Particulate
Time (hours) DEP CB DQ12
I.T. instillation Pulmonary cells 2 NSD ———— ————
(In vivo) 6 ↑ ↑↑ ↑↑
24 NSD ———— ————
Pulmonary IL-6 6 ↑ ↑ NSD
Pulmonary TNFα 6 NSD NSD NSD
Pulmonary CRP 6 NSD ↑↑ ↑↑
Plasma IL-6 6 NSD NSD NSD
Plasma TNFα 6 NSD NSD NSD
Plasma CRP 6 NSD ↑↑ ↑↑
Thrombosis 2 NSD ———— ————
6 ↑ NSD NSD
24 NSD ———— ————
tPA:PAI-1 6 ↓↓ ↓↓ ↓↓
PMA ↑↑ NSD NSD
I.V. injection Pulmonary cells 2 NSD ———— ————
(In vivo) 6 NSD NSD ————
24 NSD ———— ————
Pulmonary IL-6 2 L.O.D L.O.D. ————
Pulmonary TNFα 2 NSD NSD ————
Pulmonary CRP 2 NSD NSD ————
Plasma IL-6 2 NSD NSD ————
Plasma TNFα 2 NSD NSD ————
Plasma CRP 2 NSD ↑↑ ————
Thrombosis 2 ↑ ———— ————
6 NSD NSD ————
24 NSD ———— ————
tPA:PAI-1 6 ↓↓ ↓↓ ————
PMA 24 ↑ NSD ————
Cultured HUVECs tPA transcripts Basal ↓ ———— ————
In vitro Stimulated NSD ———— ————
PAI-1 transcripts Basal NSD ———— ————
Stimulated ↓ ———— ————
tPA antigen 6 NSD ———— ————
24 ↓↓ ———— ————
PAI-1 activity 6 ↓↓ ———— ————
24 ↓↓ ———— ————
CB carbon black, CRP C-reactive protein, DEP diesel exhaust particles, DQ12 quartz particles, HUVEC human umbilical vein endothelial cells, IL-6 interleukin 6,
PAI-1 plasminogen activator inhibitor, PMA platelet monocyte aggregation, TNFα tumour necrosis factor-α, tPA tissue plasminogen activator
NSD = no significant difference.——— = not tested (note, DQ12 was not tested by iv injection or cultured endothelial cells as this particle is unlikely to cross from
the lungs into the circulation due to its micrometre size)
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formation [13]. We addressed the proposal that DEP
could accelerate thrombus formation by direct interaction
with the cardiovascular system using i.v administration of
DEP (0.5 mg/kg) or control (CB) particles. The dose
selected was based on previous i.v. exposures in rats (0.01-
0.5 mg/kg; [21, 23, 31]. As expected i.v. injection of parti-
cles did not cause pulmonary inflammation.
Enhanced thrombus formation 2 h after i.v. injection
of DEP is consistent with the proposal that this response
is not secondary to inflammation. Interestingly, injection
of CB (which also accelerated thrombus formation) did
increase plasma CRP adding to the evidence that CB is
not an “inert” control particle [41, 44]). This suggests
that the nanocarbon core of injected DEP contributes to
its pro-thrombotic action. This may be through direct
interaction with the endothelium or generation of free
radicals [45]. Certainly, CB (which models the nanocarbon
core of DEP) alters endothelial cell function [41, 44], in-
cluding inhibiting t-PA expression and protein production
in cultured HUVECs [46]. The reduced t-PA:PAI-1 ratio
observed after injection of DEP or CB suggests that alter-
ations in endogenous fibrinolysis contribute to accelerated
thrombosis following i.v. administration.
The use of cultured HUVECs demonstrated that DEP
can alter endogenous fibrinolysis through direct inter-
action with the vascular endothelium. In the current in-
vestigation there was a pattern for lower thrombin-
induced release of t-PA in cultured endothelial cells after
exposure to DEP but this did not achieve signifi-
cance [47]. However, our results are consistent with the
suggestion that DEP can alter the endogenous fibrino-
lytic system by direct interaction with endothelial cells.
Whether this occurs in vivo is debatable since the con-
centrations of DEP used were high and unlikely to be ex-
perienced by endothelial cells following pulmonary or
systemic administration.
Particle administration to the blood in vitro directly
activates platelets [5, 13, 43]. Since nanoparticles may
translocate into the systemic circulation [48], it remains
possible that inhaled particles could interact directly
with platelets to accelerate thrombosis. In support of this
notion, a reduction in platelet number (6 h) following
i.v. injection of DEP in rats has been attributed to re-
moval of aggregated platelets from the circulation [23].
Furthermore, the pro-thrombotic response to DEP has
been linked to changes in platelet function [11, 13, 21, 49].
As with IT instillation, i.v. injection increased platelet-
monocyte interaction, co-incident with accelerated
thrombosis. Because both DEP and CB have been
shown to be internalised by platelets [50], the ability of
DEP to activate platelets is likely to be mediated by
chemical species on the surface of DEP. Further studies
are required to more precisely determine the mechanisms
of DEP-induced platelet activation, including the role of
platelet surface makers and glycoproteins [49, 50], inter-
action with circulating leucocytes and the blood vessel
wall [51], changes in catecholamines [52] and the alter-
ations in other blood constituents in susceptible models
[53, 54]. Overall, these findings suggest that platelet acti-
vation, independent of pulmonary or systemic inflamma-
tion, contributes to the accelerated thrombus formation
induced by DEP.
Limitations
Identifying the mechanisms responsible for particle-
induced acceleration of thrombus formation has proved
challenging despite considerable research effort. The
current study suggests a mechanism independent of sys-
temic and pulmonary inflammation. It was designed to
compare DEP suitable control particles, showing that
particle induced inflammation does not necessarily in-
crease thrombosis. As with all investigations, however,
consideration must be given to potential limitations. An
alternative approach to addressing this mechanism
would be to use anti-inflammatory drugs or to study
DEP-induced thrombosis in transgenic animals with im-
paired inflammatory pathways. The doses/exposures
used in the experiments described here are higher than
would be expected in the real world and are designed to
provide conceptual insight into the mechanisms in-
volved. They are also, however, single exposures in
healthy animals; it is possible that chronic exposure of
lower doses could be detrimental and may also have
more effect in patients with underlying cardiovascular
and/or respiratory disease. Furthermore, the magnitude
of the effects produced is striking, suggesting that even
lower levels could produce prominent effects in the
blood. Blood thrombogenicity plays a key role in cardio-
vascular health and small imbalances towards increased
clotting are associated with marked increases in the risk
of cardiovascular events in patients with coronary artery
disease and stroke.
Conclusions
This study has used comparison with control particles and
different routes of administration to demonstrate that
DEP-mediated acceleration of thrombosis in vivo is inde-
pendent of systemic and pulmonary inflammation. DEP
directly altered components of the endogenous fibrinolytic
system in endothelial cells but these changes alone could
not account for the acceleration of thrombus formation. In
contrast, platelet activation in response to DEP did not re-
quire pulmonary or systemic inflammation and may play
an important role in increased thrombus formation. Al-
though nanoparticle translocation is possible [48, 55–57], it
seems unlikely that it would result in sufficient exposure to
account for the acute acceleration of thrombus following
instillation or inhalation [58]. Furthermore, similar changes
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in fibrinolytic function have been reported following pul-
monary administration of DQ12 quartz, a particle con-
sidered too large to translocate [19, 20]. It is possible
that this DEP-induced increase in thrombosis contrib-
utes to the increased cardiovascular disease risk in indi-
viduals exposed to vehicle emissions but whether this is
the case remains to be determined.
Methods
Particle suspensions
Diesel exhaust particles (DEP; 1 mg/mL; Standard Refer-
ence Material 2975; National Institute of Standards and
Technology (NIST) Gaithersburg, MD, USA), nano-Carbon
Black (CB; 1 mg/mL; Printex90, Degussa, Germany) and
quartz microparticles (0.25 mg/mL; DQ12, IUF, Germany)
were suspended in sterile 0.9 % saline (in vivo experiments)
or culture medium (EGM-2; Lonza Walkersville, USA; in
vitro experiments) and dispersed by sonication
(5 min; 70 % power, 5 cycles/s; Status Homogenisers,
Philip Harris Scientific, UK). Suspensions were pre-
pared immediately before use and were endotoxin free
(Limulus Amebocyte Lysate assay, Cambrex, USA;
[41]; data not shown). CB lacks the organic and metal
constituents of DEP and represents a ‘clean’ carbon
particle of a similar primary particle size to DEP.
DQ12 quartz particles induce pulmonary inflamma-
tion but do not translocate from the lung due to their
large particle diameter (~1 μm; [20]).
Impact of particle administration on thrombosis in vivo
Animal work was performed under Home Office Li-
cence (UK) in accordance with the Animals (Scientific
Procedures) Act, 1986 and following local ethical com-
mittee review. Adult male Wistar Rats (Charles River,
UK; 175–275 g) were housed under standard light cycle
(lights on 08:00-20:00) and temperature (21–22 °C).
Administration of particle suspensions
Rats were anaesthetised by inhalation of isoflurane (Merial;
Essex, UK) prior to administration of suspensions (0.5 mL)
of DEP (1 mg/mL), CB (1 mg/mL) or DQ12 quartz
(0.25 mg/mL; a dose previously shown to induce significant
pulmonary inflammation) by intra-tracheal (IT) instillation
[34]. A separate group of rats received 0.5 mL (0.5 mg/kg)
DEP or CB suspensions, or vehicle (0.9 % saline), via tail
vein intravenous (IV) injection.
Carotid artery thrombosis
Arterial thrombus was induced by application of ferric
chloride (FeCl3; adapted from [59]). Briefly, carotid ar-
tery blood flow was measured in anaesthetised (isoflurane)
rats using an ultrasonic flow probe (Transonic Systems
Inc, Netherlands). FeCl3 solution (20 %) was applied topic-
ally to the carotid artery (10 min), arterial blood flow
monitored, and the time to cessation of blood flow
recorded.
Tissue retrieval
Rats were killed by exsanguination. Blood was collected
from the abdominal aorta, citrated (10:1 in 3.8 % sodium
citrate solution), and either analysed immediately (flow
cytometry) or stored as plasma. Tissues (carotid artery,
kidney, liver, lung) were processed for histological ana-
lysis. Serial sections (4 μm thick) were stained with
hematoxylin and eosin.
Bronchoalveolar lavage fluid collection and analysis
Bronchoalveolar lavage fluid (BALF) was obtained post-
mortem by lavaging with sterile 0.9 % saline, centrifuged
(180 g, 5 min, 4 °C) and the supernatant stored (−80 °C)
for analysis. The cell pellet was re-suspended and a total
cell count performed by an automatic cell counter (Che-
moMetec A/S. Denmark). Additionally, cells (1 × 106 cells
per 300 μL) were re-suspended in saline containing 0.1 %
bovine serum albumin, cytocentrifuged (300 rpm; 3 min)
onto glass microscope slides (Superfrost Plus; VWR Inter-
national Ltd, UK) and stained with Diff-Quick (Raymond
Lamb, UK) for differential cell counting [19]. Lactate de-
hydrogenase (LDH) was measured using the Cytotoxicity
Detection Kit (Roche Diagnostics, UK), according to
manufacturer’s instructions.
Pro-inflammatory cytokines in the lungs and systemic
circulation
Plasma and BALF were assessed for inflammatory markers
(interleukin (IL)-6, C reactive protein (CRP) and tumour
necrosis factor alpha (TNFα)) by ELISA (R&D Systems,
UK) to manufacturer’s instructions, using an automated
Triturus ELISA analyser (Grifols, Spain).
Endogenous fibrinolysis
Plasma samples were assessed for t-PA and active PAI-1
using commercially-available ELISA kits (Patricell
Ltd, UK).
Platelet-monocyte aggregation
Platelet-monocyte aggregates were measured by flow cy-
tometry using fluorescein isothiocyanate (FITC)-labelled
anti-rat CD42d antibody [60] and phycoerythrin (PE)-la-
belled hamster anti-rat CD61 [61]. PE-labelled hamster
IgG1κ was used as a negative isotype control (antibodies
from BD Biosciences, UK). Samples were analysed by
BD FACscan flow cytometer equipped with CellQuest
software for data acquisition and FlowJo software for
data analysis. Platelet-monocyte aggregates were defined
as double positive for CD42d and CD61.
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The endogenous fibrinolytic pathway in HUVECs
Human umbilical vein endothelial cells (HUVECs; Promo-
cell, Germany; Passage ≤6) were maintained in EGM-2.
Confluent HUVECs were exposed to DEP (10–150 μg/
mL) or vehicle (medium alone) for 2–24 h. Following
exposure, cells and supernatants were stored (−80 °C) for
subsequent analysis. Alternatively, DEP suspensions were
removed and the cells stimulated with thrombin (0.1–1
U/mL; 24 h) before harvesting. The effect of DEP on cell
viability was assessed by LDH assay (Cyotoxicity Detection
kit; Roche Diagnostics, UK).
Concentrations of t-PA (antigen and activity) and PAI-1
(activity) in HUVEC supernatants were measured by
ELISA, to manufacturer’s instructions (t-PA Combi Acti-
bind ELISA kit and TECHNOZYM® PAI-1 Actibind®
ELISA kit; Technoclone Ltd, UK). RNA was extracted
from HUVECs and reverse transcribed to cDNA in order
to measure t-PA and PAI-1 expression by real time poly-
merase chain reaction (PCR). Real time PCR primers
(Invitrogen; UK; Additional file 3: Table S1) and probes
(Roche Universal Probe library) were designed by the
Roche UPL Design Centre (Roche, UK) using the species-
specific gene and nucleotide sequences. Samples were
analysed using a Roche LightCycler 480 and normalised to
the housekeeping genes GAPDH and β-actin. Additional
reagents were purchased from Sigma-Aldrich (UK).
Statistics
Data are expressed as mean ± s.e.mean, n = 6 unless other-
wise indicated. Results were analysed using GraphPad
Prism software. Analyses were performed using Student’s
unpaired, two-tailed t-test, one-way ANOVA followed by
Tukey’s multiple comparison post-test or two-way
ANOVA with a Bonferroni post-test. Equality of variance
was confirmed using an F test or Kolmogorov-Smirnov
test. Significance was assumed when P < 0.05.
Additional files
Additional file 1: Figure S1. Intravenous administration of DEP does
not increase systemic CRP or pulmonary pro-inflammatory cytokines.
Intravenous injection of DEP (black columns) or CB (light grey columns)
did not increase bronchoalveolar lavage fluid concentrations of (i) TNF-α
or (ii) C-reactive protein (CRP) when compared to saline (white column)
collected 2 h after injection. Levels of IL-6 were below the limit of detection.
(iii) Systemic inflammation was assessed by measuring CRP in plasma taken
from rats 2 h (the time-point at which thrombus formation was increased
by DEP) after intravenous injection of diesel exhaust particulate (DEP)
or carbon black (CB). CB (light grey column), increased plasma concentrations
of CRP whereas DEP did not (black column). Data are mean ± s.e.mean
(n = 6) and were compared using Student’s unpaired t-test ((i) & (ii))
or one-way ANOVA (iii); ns = not significant ***P < 0.001 compared
with saline-treated control. (TIF 55 kb)
Additional file 2: Figure S2. Assessment of cytotoxicity in endothelial
cells exposed to DEP suspensions. Cell death was induced in human
umbilical vein endothelial cells by exposure (24 h) to (a) H2O2 (1–1000 μM;
n = 1) or (b) Tween 20 (0.1–10 %; n = 1) (c) but not by diesel exhaust
particles (DEP; 10–80 μg/ml) after 2 (red), 6 (blue) 16 (green) or 24
(purple) hours incubation. Data are mean ± s.e.mean (n = 6). (TIF 81 kb)
Additional file 3: Table S1. Real time polymerase chain reaction primers.
(TIF 53 kb)
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